Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

126: How Can Digital Pathology Workflows Stay Compliant and Efficient w/ Scott Randall, Hamamatsu and and Amanda Coble, Proscia

40:26
 
Share
 

Manage episode 471533020 series 3404634
Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

How Can Digital Pathology Workflows Stay Compliant and Efficient?

In this episode of the Digital Pathology Podcast, I sit down with Scott Randall, Senior Application Specialist at Hamamatsu (Hamamatsu NanoZoomer), and Amanda Coble, Senior Director of Product for Proscia (Proscia’s Website), to discuss the critical role of compliance, interoperability, and efficiency in digital pathology workflows.

🔬 Key Topics Covered:

  • [00:00:00] Introduction and Initial Challenges in Digital Pathology Compliance
  • [00:01:00] Guest Introductions: Meet Scott and Amanda
  • [00:03:00] Hamamatsu’s FDA Clearance Journey: Lessons Learned
  • [00:06:00] Proscia’s Path to FDA Clearance and Partnering with Hamamatsu
  • [00:10:00] How Digital Pathology Systems Maintain Compliance
  • [00:14:00] The Advantages of Open Architecture in Digital Pathology
  • [00:18:00] Overcoming Challenges in Slide Scanning and Logistics
  • [00:22:00] Phases of Digital Pathology Adoption and Future-Proofing Labs
  • [00:27:00] The Role of AI and Automation in Digital Pathology Workflows
  • [00:32:00] Advice for Vendors Looking to Build Compliant Digital Pathology Solutions
  • [00:38:00] Final Thoughts: The Future of Interoperability and Compliance

🩺 Why This Episode Matters:
Regulatory approval in digital pathology isn’t just about scanning slides—it’s about building a seamless, interoperable workflow that ensures accuracy, efficiency, and compliance. Hamamatsu and Proscia were among the first companies to successfully achieve FDA clearance for their integrated solutions, setting the stage for future innovations in AI-powered digital pathology.

Episode Resources:

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  continue reading

137 episodes

Artwork
iconShare
 
Manage episode 471533020 series 3404634
Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

How Can Digital Pathology Workflows Stay Compliant and Efficient?

In this episode of the Digital Pathology Podcast, I sit down with Scott Randall, Senior Application Specialist at Hamamatsu (Hamamatsu NanoZoomer), and Amanda Coble, Senior Director of Product for Proscia (Proscia’s Website), to discuss the critical role of compliance, interoperability, and efficiency in digital pathology workflows.

🔬 Key Topics Covered:

  • [00:00:00] Introduction and Initial Challenges in Digital Pathology Compliance
  • [00:01:00] Guest Introductions: Meet Scott and Amanda
  • [00:03:00] Hamamatsu’s FDA Clearance Journey: Lessons Learned
  • [00:06:00] Proscia’s Path to FDA Clearance and Partnering with Hamamatsu
  • [00:10:00] How Digital Pathology Systems Maintain Compliance
  • [00:14:00] The Advantages of Open Architecture in Digital Pathology
  • [00:18:00] Overcoming Challenges in Slide Scanning and Logistics
  • [00:22:00] Phases of Digital Pathology Adoption and Future-Proofing Labs
  • [00:27:00] The Role of AI and Automation in Digital Pathology Workflows
  • [00:32:00] Advice for Vendors Looking to Build Compliant Digital Pathology Solutions
  • [00:38:00] Final Thoughts: The Future of Interoperability and Compliance

🩺 Why This Episode Matters:
Regulatory approval in digital pathology isn’t just about scanning slides—it’s about building a seamless, interoperable workflow that ensures accuracy, efficiency, and compliance. Hamamatsu and Proscia were among the first companies to successfully achieve FDA clearance for their integrated solutions, setting the stage for future innovations in AI-powered digital pathology.

Episode Resources:

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  continue reading

137 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play